Call(s) to Action: None Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) ChinaHybrids CHSTY ($21.11) – Taking a closer look at CHSTY because the company has reported profits for first half of […]
Summary We offer a rebuttal to all four of XXII’s counterarguments to our piece published Wednesday (yesterday) morning. Rather than worry about the nuanced arguments XXII made in its rebuttal, we believe investors should be more interested in what XXII […]
Andatee China Marine Fuel(NASDAQ:AMCF)($2.58) – a leading independent operator engaged in the production, storage, distribution, trading of blended marine fuel oil for cargo and fishing vessels, as well as research and development of clean energy solution in China, today announced […]
Call(s) to Action: Stay tuned for our next short thesis report to be released later this morning. Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) ChinaHybrids VIMC ($3.50) – Reported strong Q2 […]
Summary A number of factors lead us to the conclusion that 22nd Century Group (XXII) is severely overvalued and likely worth no more than $0.20 per share. In the past, the SEC charged XXII CEO Joseph Pandolfino, Jr. for stock […]
Apptigo International (APPG) is one of the most obvious pump and dump (P&D) cases we have come across since we began investigating P&D’s in our inaugural report Raystream (RAYS), which now trades at $0.001. Some of the characters associated with […]
Call(s) to Action: Please stay tuned for a report on two Pharmaceutical companies competing to use a cannabis-based compound to treat a specific condition in children. One of the companies is a bullish call, and the other bearish. Here are […]
Summary Cannabidiol (“CBD”), a cannabis-based substance, is the focus of INSY and GWPH, two companies competing to develop CBD for the treatment of Dravet Syndrome, a form of childhood epilepsy. Contrary to what appears to be respected analysts’ expectations, INSY […]